lenalidomide maintenance – an active approach to treating mm?
Published 7 years ago • 164 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:08
lenalidomide maintenance in mm: data update
-
1:30
the impact of lenalidomide maintenance therapy on myeloma patients in the uk
-
8:40
lenalidomide, mutations & mds outcomes
-
2:21
lenalidomide maintenance therapy in patients with multiple myeloma and high-risk cytogenetics
-
9:25
mgus diagnosis: a step-by-step approach
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
1:25
lenalidomide maintenance remains best for newly diagnosed mm
-
1:43
alternative options for mm patients relapsing under lenalidomide
-
2:24
myeloma: lenalidomide maintenance therapy
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:21
vrd induction, mel200-conditioned autohsct and lenalidomide maintenance in multiple myeloma
-
1:15
sintra-rev update: early lenalidomide treatment in non-transfusion dependent del(5q) lr-mds
-
2:31
uk practice: pomalidomide in patients resistant to lenalidomide
-
1:48
do all patients require maintenance therapy following allosct?
-
2:02
evaluating the optimal duration of lenalidomide maintenance after autosct using data from myeloma xi
-
1:09
lenalidomide's place in the myeloma treatment landscape
-
1:45
long-term findings from mcl0208: lenalidomide maintenance post autosct in mcl
-
1:33
safety of lenalidomide maintenance therapy in myeloma patients following transplantation
-
3:49
gmmg-hd4 and mm5: bortezomib vs. lenalidomide for myeloma maintenance